US Stock MarketDetailed Quotes
ELAN Elanco Animal Health
- 13.260
- +0.220+1.69%
Close Apr 26 16:00 ET
- 13.260
- 0.0000.00%
Post 16:01 ET
6.55BMarket Cap-5304P/E (TTM)
13.360High12.920Low3.25MVolume13.030Open13.040Pre Close43.20MTurnover0.66%Turnover RatioLossP/E (Static)494.10MShares16.88052wk High1.05P/B6.52BFloat Cap7.88052wk Low--Dividend TTM491.64MShs Float37.610Historical High--Div YieldTTM3.37%Amplitude7.880Historical Low13.274Avg Price1Lot Size
Elanco Animal Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.14%4.42B | 5.08%1.04B | 4.09%1.07B | -10.04%1.06B | 2.53%1.26B | -7.41%4.41B | -11.42%985M | -9.28%1.03B | -8.13%1.18B | -1.29%1.23B |
| Operating revenue | 0.14%4.42B | 5.08%1.04B | 4.09%1.07B | -10.04%1.06B | 2.53%1.26B | -7.41%4.41B | -11.42%985M | -9.28%1.03B | -8.13%1.18B | -1.29%1.23B |
| Cost of revenue | 0.94%1.93B | 15.18%516M | 3.18%487M | -10.33%434M | -2.95%494M | -10.27%1.91B | -12.16%448M | -5.98%472M | -12.16%484M | -10.54%509M |
| Gross profit | -0.48%2.49B | -3.35%519M | 4.87%581M | -9.84%623M | 6.42%763M | -5.09%2.5B | -10.80%537M | -11.92%554M | -5.08%691M | 6.54%717M |
| Operating expense | 2.18%2.16B | -0.59%509M | 6.94%539M | 2.15%570M | 0.18%542M | -9.19%2.11B | -8.41%512M | -12.65%504M | -8.22%558M | -7.36%541M |
| Selling and administrative expenses | 1.58%1.29B | -3.31%292M | 5.03%313M | 2.92%353M | 1.24%327M | -9.84%1.27B | -7.93%302M | -12.87%298M | -10.91%343M | -7.18%323M |
| Research and development costs | 1.87%327M | -1.25%79M | 10.26%86M | -1.22%81M | 0.00%81M | -13.01%321M | -13.04%80M | -17.02%78M | -12.77%82M | -8.99%81M |
| Depreciation amortization depletion | 3.79%548M | 6.15%138M | 9.38%140M | 2.26%136M | -2.19%134M | -5.04%528M | -6.47%130M | -9.22%128M | 3.10%133M | -6.80%137M |
| -Depreciation and amortization | 3.79%548M | 6.15%138M | 9.38%140M | 2.26%136M | -2.19%134M | -5.04%528M | -6.47%130M | -9.22%128M | 3.10%133M | -6.80%137M |
| Operating profit | -15.10%326M | -60.00%10M | -16.00%42M | -60.15%53M | 25.57%221M | 26.32%384M | -41.86%25M | -3.85%50M | 10.83%133M | 97.75%176M |
| Net non-operating interest income expense | -14.94%-277M | -8.06%-67M | -20.00%-72M | -10.45%-74M | -23.08%-64M | -2.12%-241M | -12.73%-62M | 0.00%-60M | -11.67%-67M | 14.75%-52M |
| Non-operating interest expense | 14.94%277M | 8.06%67M | 20.00%72M | 10.45%74M | 23.08%64M | 2.12%241M | 12.73%62M | 0.00%60M | 11.67%67M | -14.75%52M |
| Other net income (expense) | -478.60%-1.24B | -34.62%-70M | -3,038.24%-1.07B | 27.50%-58M | 0.00%-49M | 66.35%-215M | 53.98%-52M | 72.13%-34M | 72.97%-80M | 54.63%-49M |
| Special income (charges) | -538.80%-1.17B | -16.13%-36M | -3,969.23%-1.06B | 59.30%-35M | 0.00%-40M | 71.14%-183M | 65.56%-31M | 78.33%-26M | 71.99%-86M | 65.81%-40M |
| -Less：Restructuring and merger&acquisition | -5.10%93M | -75.00%7M | -59.26%11M | 40.00%35M | 122.22%40M | -63.97%98M | -73.33%28M | -3.57%27M | -19.35%25M | -83.18%18M |
| -Less:Impairment of capital assets | 1,225.93%1.07B | 2,800.00%27M | 104,800.00%1.05B | --0 | --0 | -76.86%81M | -108.33%-1M | -101.79%-1M | -78.23%59M | 100.00%22M |
| -Less:Other special charges | -50.00%2M | ---- | ---- | ---- | ---- | -66.67%4M | ---- | ---- | -60.00%2M | ---- |
| Other non- operating income (expenses) | -134.38%-75M | -61.90%-34M | -12.50%-9M | -483.33%-23M | 0.00%-9M | -540.00%-32M | 8.70%-21M | -300.00%-8M | -45.45%6M | -200.00%-9M |
| Income before tax | -1,559.72%-1.2B | -42.70%-127M | -2,393.18%-1.1B | -464.29%-79M | 44.00%108M | 87.39%-72M | 28.80%-89M | 66.15%-44M | 94.07%-14M | 193.75%75M |
| Income tax | 500.00%36M | 140.00%14M | -104.76%-1M | 550.00%18M | -79.17%5M | 106.82%6M | -105.88%-35M | 180.77%21M | 84.62%-4M | 226.32%24M |
| Net income | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M | 37.50%-65M | 95.24%-10M | 183.61%51M |
| Net income continuous Operations | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M | 37.50%-65M | 95.24%-10M | 183.61%51M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M | 37.50%-65M | 95.24%-10M | 183.61%51M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M | 37.50%-65M | 95.24%-10M | 183.61%51M |
| Basic earnings per share | -1,462.50%-2.5 | -163.64%-0.29 | -1,607.69%-2.22 | -900.00%-0.2 | 110.00%0.21 | 83.84%-0.16 | 45.00%-0.11 | 38.10%-0.13 | 95.35%-0.02 | 183.33%0.1 |
| Diluted earnings per share | -1,462.50%-2.5 | -163.64%-0.29 | -1,607.69%-2.22 | -900.00%-0.2 | 110.00%0.21 | 83.84%-0.16 | 45.00%-0.11 | 38.10%-0.13 | 95.35%-0.02 | 183.33%0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg